ID 445396884 · FY 2018–2024 · 7 years
მისი ძირითადი საქმიანობაა ინტერვენციული კარდიოლოგიური სახარჯი მასალების რეალიზაცია.
Bars are revenue on the left axis; lines are EBITDA and net margin on the right.
| Ratio | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Margins | |||||||
| Gross Margin | 33.6% | 34.2% | 30.0% | 22.3% | 31.1% | 35.2% | 34.8% |
| EBITDA Margin | 28.6% | 29.5% | 24.9% | 19.7% | 26.7% | 30.6% | 31.2% |
| EBITDAR | 1,094 | 1,233 | 871 | 1,355 | 1,491 | 1,916 | 2,168 |
| EBITDAR Margin | 28.6% | 29.5% | 24.9% | 19.7% | 26.7% | 30.7% | 31.3% |
| EBIT Margin | 28.3% | 29.4% | 24.7% | 19.6% | 26.6% | 30.4% | 31.1% |
| Net Profit Margin | 26.9% | 25.7% | 22.8% | 17.9% | 25.2% | 29.0% | 29.4% |
| Operating Expense % of Sales | 5.1% | 4.7% | 5.1% | 2.6% | 4.4% | 4.6% | 3.6% |
| Returns | |||||||
| Return on Assets (ROA) | 34.7% | 35.4% | 24.6% | 30.3% | 27.5% | 28.3% | 24.8% |
| Return on Equity (ROE) | 50.6% | 40.5% | 24.8% | 30.9% | 27.8% | 28.4% | 25.7% |
| ROIC [EBIT / Invested Capital] | 60.1% | 51.7% | 38.8% | 48.6% | 39.2% | 42.2% | 34.6% |
| Leverage & debt balances | |||||||
| Debt-to-Assets | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 2.8% |
| Debt-to-Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.03x |
| Debt-to-EBITDA | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.11x |
| Equity-to-Assets | 68.6% | 87.4% | 99.2% | 98.3% | 98.7% | 99.6% | 96.5% |
| Net Debt | -233 | -286 | -979 | -1,229 | -1,267 | -1,872 | -1,695 |
| Cash & Equivalents | 233 | 286 | 979 | 1,229 | 1,267 | 1,872 | 1,927 |
| Total Debt | N/A | N/A | N/A | N/A | N/A | N/A | 232 |
| Liquidity & working capital | |||||||
| Current Ratio | N/A | N/A | N/A | N/A | 67.04x | 249.05x | 47.49x |
| Quick Ratio | N/A | N/A | N/A | N/A | 67.04x | 249.05x | 47.49x |
| Cash Ratio | N/A | N/A | N/A | N/A | 18.98x | 80.89x | 13.67x |
| Total Current Assets | 2,831 | 2,902 | 3,064 | 3,910 | 4,477 | 5,764 | 6,692 |
| Total Current Liabilities | N/A | N/A | N/A | N/A | 67 | 23 | 141 |
| Inventory | N/A | 829 | 683 | 747 | N/A | N/A | N/A |
| Trade Receivables | 1,976 | 1,766 | 1,387 | 1,917 | 1,717 | 2,822 | 3,472 |
| Trade Payables | 687 | 379 | 18 | 60 | 57 | 9 | 21 |
| Net Working Capital | 2,831 | 2,902 | 3,064 | 3,910 | 4,411 | 5,741 | 6,551 |
| Net Working Capital % of Revenue | 73.9% | 69.5% | 87.7% | 56.8% | 79.1% | 92.1% | 94.6% |
| Trade Working Capital | 1,289 | 2,216 | 2,052 | 2,603 | 1,659 | 2,813 | 3,451 |
| Trade Working Capital % of Revenue | 33.6% | 53.1% | 58.7% | 37.8% | 29.8% | 45.1% | 49.8% |
| Change in Trade Working Capital | N/A | 927 | -164 | 552 | -944 | 1,154 | 638 |
| Turnover & efficiency | |||||||
| Inventory Turnover | N/A | 3.31x | 3.58x | 7.16x | N/A | N/A | N/A |
| Days Inventory Outstanding (DIO) | N/A | 110.1 | 101.9 | 51.0 | N/A | N/A | N/A |
| Receivables Turnover | 1.94x | 2.36x | 2.52x | 3.59x | 3.25x | 2.21x | 1.99x |
| Days Sales Outstanding (DSO) | 188.2 | 154.4 | 145.0 | 101.7 | 112.4 | 165.2 | 183.0 |
| Payables Turnover | 3.70x | 7.25x | 134.34x | 88.94x | 66.99x | 445.56x | 213.60x |
| Days Payable Outstanding (DPO) | 98.6 | 50.3 | 2.7 | 4.1 | 5.4 | 0.8 | 1.7 |
| Cash Conversion Cycle | 89.6 days | 214.3 days | 244.2 days | 148.5 days | 106.9 days | 164.3 days | 181.3 days |
| Asset Turnover | 1.29x | 1.37x | 1.08x | 1.69x | 1.09x | 0.97x | 0.85x |
| Cash flow & dividends | |||||||
| Operating Cash Flow | N/A | 53 | 693 | 250 | 39 | 605 | 55 |
| Free Cash Flow (OCF − Capex proxy) | N/A | 53 | 693 | 250 | 39 | 605 | 55 |
| Cash Conversion (OCF / EBITDA) | N/A | 4.3% | 79.5% | 18.4% | 2.6% | 31.7% | 2.6% |
| Dividends Declared | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividend Payout Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in ₾ '000. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Companies sharing this sector, ranked by how close their latest revenue is to this one — not a curated comp set.